EVALUATING METACOGNITIVE THERAPY TO IMPROVE TREATMENT OF ANXIETY AND DEPRESSION IN CARDIOVASCULAR DISEASE THE NIHR FUNDED PATHWAY RESEARCH PROGRAMME

Wells, A., Reeves, D., Heal, C., Davies, L. M., Shields, G. E., Heagerty, A., … & Capobianco, L. (2022). Evaluating metacognitive therapy to improve treatment of anxiety and depression in cardiovascular disease: the NIHR funded pathway research programme. Frontiers in psychiatry, 13, 886407. 

Background: One in three cardiovascular disease (CVD) patients experience significant anxiety and depression. Current psychological interventions have limited efficacy in reducing such symptoms and are offered as a face-to-face intervention that may be a barrier to accessing treatment. We evaluated the feasibility and acceptability of delivering assisted home-based self-help metacognitive therapy (home-MCT) to cardiac rehabilitation (CR) patients experiencing anxiety and depression.